EE9500071A - Tsükloalkanindool- ja asaindoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud derivaate sisaldavad ravimid ning karboksüülhapped kui vaheühendid nimetatud tsükloalkaanindool- ja asaindoolderivaatide valmistamiseks - Google Patents

Tsükloalkanindool- ja asaindoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud derivaate sisaldavad ravimid ning karboksüülhapped kui vaheühendid nimetatud tsükloalkaanindool- ja asaindoolderivaatide valmistamiseks

Info

Publication number: EE9500071A
Authority: EE; Estonia
Prior art keywords: opt; substd; alkyl; derivatives; cycloalkanindole
Prior art date: 1994-10-04

Application number

EE9500071A

Other languages

English (en)

Other versions

EE03527B1 (et

Inventor

M�ller Ulrich

Connell Richard

Goldmann Siegfried

Gr�tzmann Rudi

Beuck Martin

Bischoff Hilmar

Denzer Dirk

Domdey-Bette Anke

Wohlfeil Stefan

Original Assignee

Bayer Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-04

Filing date

1995-10-03

Publication date

1996-04-15

1995-10-03 Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft

1996-04-15 Publication of EE9500071A publication Critical patent/EE9500071A/et

2001-10-15 Publication of EE03527B1 publication Critical patent/EE03527B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

EE9500071A 1994-10-04 1995-10-03 Tsükloalkaanindool- ja -asaindoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud derivaate sisaldavad ravimid ning karboksüülhapped kui vaheühendid nimetatud tsükloalkaanindool- ja -asaindoolderivaatide valmistamise EE03527B1 (et)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4435477A DE4435477A1 (de)	1994-10-04	1994-10-04	Cycloalkano-indol- und -azaindol-derivate

Publications (2)

Publication Number	Publication Date
EE9500071A true EE9500071A (et)	1996-04-15
EE03527B1 EE03527B1 (et)	2001-10-15

Family

ID=6529939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9500071A EE03527B1 (et)	1994-10-04	1995-10-03	Tsükloalkaanindool- ja -asaindoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud derivaate sisaldavad ravimid ning karboksüülhapped kui vaheühendid nimetatud tsükloalkaanindool- ja -asaindoolderivaatide valmistamise

Country Status (35)

Country	Link
US (6)	US5684014A (et)
EP (1)	EP0705831B1 (et)
JP (1)	JP3901234B2 (et)
KR (1)	KR100355986B1 (et)
CN (2)	CN1050605C (et)
AT (1)	ATE255580T1 (et)
AU (1)	AU700609B2 (et)
CA (1)	CA2159546C (et)
CZ (1)	CZ291348B6 (et)
DE (2)	DE4435477A1 (et)
DK (1)	DK0705831T3 (et)
DZ (1)	DZ1934A1 (et)
EE (1)	EE03527B1 (et)
ES (1)	ES2211890T3 (et)
FI (2)	FI113048B (et)
HN (1)	HN1995009160A (et)
HR (1)	HRP950505B1 (et)
HU (1)	HU225052B1 (et)
IL (3)	IL129641A0 (et)
MA (1)	MA23683A1 (et)
MY (1)	MY117282A (et)
NO (1)	NO305365B1 (et)
NZ (1)	NZ280130A (et)
PH (1)	PH31400A (et)
PL (1)	PL183154B1 (et)
PT (1)	PT705831E (et)
RU (1)	RU2157803C2 (et)
SG (1)	SG63528A1 (et)
SI (1)	SI0705831T1 (et)
SK (1)	SK284260B6 (et)
SV (1)	SV1995000062A (et)
TN (1)	TNSN95098A1 (et)
TW (1)	TW448175B (et)
UA (1)	UA44700C2 (et)
ZA (1)	ZA958297B (et)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19525028A1 (de) *	1995-07-10	1997-01-16	Bayer Ag	Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
US6774236B1 (en)	1996-04-04	2004-08-10	Bayer Aktiengesellschaft	Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19613549A1 (de) *	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19619950A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) *	1996-04-17	1997-10-22	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide
DE19615265A1 (de) *	1996-04-18	1997-12-04	Bayer Ag	Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
CA2331036A1 (en) *	1998-05-01	1999-11-11	Daniel Jon Sall	Spla2 inhibitor ester
ATE258934T1 (de)	1998-10-30	2004-02-15	Lilly Co Eli	Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
AU4616200A (en) *	1999-05-25	2000-12-12	Yamanouchi Pharmaceutical Co., Ltd.	Hydrazide derivatives
DE19929065A1 (de) *	1999-06-25	2000-12-28	Bayer Ag	Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
DE19934610A1 (de) *	1999-07-23	2001-01-25	Bayer Ag	Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
AU2001237418B2 (en) *	2000-03-15	2007-01-11	Sanofi-Aventis Deutschland Gmbh	Substituted beta-carbolines with ikb-kinase inhibiting activity
EP1134221A1 (en) *	2000-03-15	2001-09-19	Aventis Pharma Deutschland GmbH	Substituted beta-carbolines as lkB kinase inhibitors
AU2001244635A1 (en) *	2000-03-30	2001-10-15	Yamanouchi Pharmaceutical Co..Ltd.	Hydrazide derivatives
DE10030375A1 (de) *	2000-06-21	2002-01-03	Bayer Ag	Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
HRP20030608A2 (en) *	2001-01-31	2005-06-30	Synaptic Pharmaceutical Corporation	Use of gal3 receptor antagonists for the treatment
GB0115109D0 (en) *	2001-06-21	2001-08-15	Aventis Pharma Ltd	Chemical compounds
WO2003072532A1 (en) *	2002-02-28	2003-09-04	Japan Tobacco Inc.	Ester compound and medicinal use thereof
US20050239780A1 (en) *	2002-05-31	2005-10-27	Akira Suga	Tetrahydropyran derivative
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
WO2004063156A1 (en) *	2003-01-08	2004-07-29	Biovitrum Ab	Novel indole derivates as fabp-4 inhibitors
WO2005051382A1 (ja) *	2003-11-28	2005-06-09	Astellas Pharma Inc.	脂質低下作用増強剤
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
NZ549721A (en)	2004-03-05	2010-08-27	Univ Pennsylvania	Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005230397B2 (en) *	2004-04-09	2010-04-08	Elanco Animal Health Ireland Limited	Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060030623A1 (en) *	2004-07-16	2006-02-09	Noboru Furukawa	Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
FR2873694B1 (fr) *	2004-07-27	2006-12-08	Merck Sante Soc Par Actions Si	Nouveaux aza-indoles inhibiteurs de la mtp et apob
US8101774B2 (en) *	2004-10-18	2012-01-24	Japan Tobacco Inc.	Ester derivatives and medicinal use thereof
MX2007004973A (es) *	2004-10-25	2007-06-14	Japan Tobacco Inc	Formulacion solida con solubilidad y estabilidad mejoradas y metodo para producir la formulacion.
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
EP1890767A2 (en) *	2005-05-27	2008-02-27	Pfizer Products Inc.	Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
JP2009503050A (ja) *	2005-08-04	2009-01-29	ファイザー・リミテッド	ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物
JP2009511634A (ja) *	2005-10-18	2009-03-19	エージェリオンファーマシューティカルズ	哺乳動物において高脂血症に関連する障害を治療する方法
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
AU2007219236B2 (en) *	2006-02-23	2012-06-21	Pfizer Limited	Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US20080051427A1 (en) *	2006-05-18	2008-02-28	Fritz Schuckler	Pharmaceutical Compositions and Methods of Using Same
AU2007320906A1 (en)	2006-11-13	2008-05-22	Pfizer Products Inc.	Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
WO2008070496A2 (en)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
JP2010513534A (ja) *	2006-12-21	2010-04-30	エージェリオンファーマシューティカルズ，インコーポレイテッド	Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法
RU2338745C1 (ru) *	2007-03-21	2008-11-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124384A2 (en) *	2007-04-03	2008-10-16	Aegerion Pharmaceuticals, Inc.	Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c
CN102171206B (zh) *	2008-08-06	2014-06-25	辉瑞股份有限公司	作为mc4激动剂的二氮杂环庚烷和二氮杂环辛烷
CA2899247C (en)	2013-03-14	2023-04-04	Osteoqc Inc.	Alkyl-amine harmine derivatives for promoting bone growth
JP6782227B2 (ja) *	2014-09-05	2020-11-11	ザ・ジョンズ・ホプキンス・ユニバーシティー	ＣａＭＫＩＩ阻害剤及びその使用
CN108218862B (zh) *	2018-02-07	2020-06-23	贵州医科大学	α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
CN110467560B (zh) *	2018-05-09	2025-11-25	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
BR112021002655A2 (pt)	2018-08-14	2021-05-04	Osteoqc Inc.	compostos flúor ss-carbolina
AU2019321434B2 (en)	2018-08-14	2025-05-08	Ossifi Therapeutics Llc	Pyrrolo - dipyridine compounds
US20230285376A1 (en)	2020-07-29	2023-09-14	Amryt Pharmaceuticals Inc.	Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH501623A (de) *	1967-12-18	1971-01-15	Ruetgerswerke Ag	Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
EP0234708B1 (en) *	1986-01-23	1991-02-27	Merck Frosst Canada Inc.	Tetrahydrocarbazole 1-alkanoic acids
US4940719A (en) *	1986-03-27	1990-07-10	Merck Frosst Canada, Inc.	Tetrahydrocarbazole esters, pharmaceutical compositions and use
CA1326030C (en) *	1987-07-21	1994-01-11	John W. Gillard	Cyclohept[b]indolealkanoic acids
US4775680A (en) *	1987-07-21	1988-10-04	Merck & Co., Inc.	Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
GB9101375D0 (en) *	1991-01-22	1991-03-06	Erba Carlo Spa	N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4112533A1 (de) *	1991-04-17	1992-10-22	Bayer Ag	Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de)	1991-04-26	1992-10-29	Bayer Ag	Heterocyclisch substituierte phenylessigsaeurederivate
DE4308788A1 (de) *	1993-03-18	1994-09-22	Bayer Ag	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19613549A1 (de)	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide

1994
- 1994-10-04 DE DE4435477A patent/DE4435477A1/de not_active Withdrawn
1995
- 1995-02-07 HN HN1995009160A patent/HN1995009160A/es unknown
- 1995-09-21 PT PT95114877T patent/PT705831E/pt unknown
- 1995-09-21 DE DE59510839T patent/DE59510839D1/de not_active Expired - Lifetime
- 1995-09-21 SI SI9530693T patent/SI0705831T1/xx unknown
- 1995-09-21 ES ES95114877T patent/ES2211890T3/es not_active Expired - Lifetime
- 1995-09-21 DK DK95114877T patent/DK0705831T3/da active
- 1995-09-21 EP EP95114877A patent/EP0705831B1/de not_active Expired - Lifetime
- 1995-09-21 AT AT95114877T patent/ATE255580T1/de not_active IP Right Cessation
- 1995-09-27 AU AU32920/95A patent/AU700609B2/en not_active Ceased
- 1995-09-27 HR HR950505A patent/HRP950505B1/xx not_active IP Right Cessation
- 1995-09-28 US US08/535,698 patent/US5684014A/en not_active Expired - Lifetime
- 1995-09-29 CA CA2159546A patent/CA2159546C/en not_active Expired - Fee Related
- 1995-09-29 NZ NZ280130A patent/NZ280130A/en not_active IP Right Cessation
- 1995-10-02 IL IL12964199A patent/IL129641A0/xx unknown
- 1995-10-02 TN TNTNSN95098A patent/TNSN95098A1/fr unknown
- 1995-10-02 KR KR1019950033651A patent/KR100355986B1/ko not_active Expired - Fee Related
- 1995-10-02 IL IL12964195A patent/IL129641A/xx not_active IP Right Cessation
- 1995-10-02 FI FI954681A patent/FI113048B/fi active
- 1995-10-02 MA MA24027A patent/MA23683A1/fr unknown
- 1995-10-02 TW TW084110247A patent/TW448175B/zh active
- 1995-10-02 DZ DZ950116A patent/DZ1934A1/fr active
- 1995-10-02 IL IL11549395A patent/IL115493A/xx not_active IP Right Cessation
- 1995-10-03 SG SG1995001478A patent/SG63528A1/en unknown
- 1995-10-03 HU HU9502891A patent/HU225052B1/hu not_active IP Right Cessation
- 1995-10-03 JP JP27966495A patent/JP3901234B2/ja not_active Expired - Fee Related
- 1995-10-03 RU RU95117070/04A patent/RU2157803C2/ru not_active IP Right Cessation
- 1995-10-03 PL PL95310756A patent/PL183154B1/pl not_active IP Right Cessation
- 1995-10-03 UA UA95104372A patent/UA44700C2/uk unknown
- 1995-10-03 SK SK1239-95A patent/SK284260B6/sk not_active IP Right Cessation
- 1995-10-03 EE EE9500071A patent/EE03527B1/et not_active IP Right Cessation
- 1995-10-03 NO NO953930A patent/NO305365B1/no not_active IP Right Cessation
- 1995-10-03 ZA ZA958297A patent/ZA958297B/xx unknown
- 1995-10-03 PH PH51415A patent/PH31400A/en unknown
- 1995-10-03 CZ CZ19952567A patent/CZ291348B6/cs not_active IP Right Cessation
- 1995-10-04 SV SV1995000062A patent/SV1995000062A/es active IP Right Grant
- 1995-10-04 MY MYPI95002964A patent/MY117282A/en unknown
- 1995-10-04 CN CN95117117A patent/CN1050605C/zh not_active Expired - Fee Related
- 1995-10-04 CN CNB981260853A patent/CN1183111C/zh not_active Expired - Fee Related
1997
- 1997-07-03 US US08/887,781 patent/US6245775B1/en not_active Expired - Lifetime
1999
- 1999-05-17 US US09/313,035 patent/US6265431B1/en not_active Expired - Lifetime
2000
- 2000-12-08 FI FI20002693A patent/FI108791B/fi active
- 2000-12-11 US US09/734,955 patent/US20020147209A1/en not_active Abandoned
2001
- 2001-03-21 US US09/814,263 patent/US6479503B2/en not_active Expired - Lifetime
2002
- 2002-07-18 US US10/198,315 patent/US6858622B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE255580T1 (de)	2003-12-15
US20020055635A1 (en)	2002-05-09
CA2159546C (en)	2010-12-14
DZ1934A1 (fr)	2002-02-17
PL310756A1 (en)	1996-04-15
SK123995A3 (en)	1996-06-05
AU3292095A (en)	1996-04-18
FI20002693L (fi)	2000-12-08
NO953930D0 (no)	1995-10-03
CN1183111C (zh)	2005-01-05
SV1995000062A (es)	1996-07-10
CN1050605C (zh)	2000-03-22
IL115493A (en)	1999-10-28
US6479503B2 (en)	2002-11-12
KR960014126A (ko)	1996-05-22
UA44700C2 (uk)	2002-03-15
JPH08225526A (ja)	1996-09-03
DE59510839D1 (de)	2004-01-15
FI113048B (fi)	2004-02-27
DK0705831T3 (da)	2004-04-05
HU9502891D0 (en)	1995-11-28
EP0705831A2 (de)	1996-04-10
TNSN95098A1 (fr)	1996-02-06
CN1130631A (zh)	1996-09-11
HRP950505A2 (en)	1997-08-31
RU2157803C2 (ru)	2000-10-20
EP0705831A3 (de)	1997-01-22
US20020147209A1 (en)	2002-10-10
CA2159546A1 (en)	1996-04-05
NO953930L (no)	1996-04-09
HUT73240A (en)	1996-07-29
EE03527B1 (et)	2001-10-15
NO305365B1 (no)	1999-05-18
IL115493A0 (en)	1996-01-19
NZ280130A (en)	1996-05-28
AU700609B2 (en)	1999-01-07
HRP950505B1 (en)	2002-04-30
US6265431B1 (en)	2001-07-24
US5684014A (en)	1997-11-04
US6245775B1 (en)	2001-06-12
DE4435477A1 (de)	1996-04-11
ES2211890T3 (es)	2004-07-16
HU225052B1 (en)	2006-05-29
CZ291348B6 (cs)	2003-02-12
PL183154B1 (pl)	2002-05-31
FI954681A7 (fi)	1996-04-05
KR100355986B1 (ko)	2003-01-06
HK1005139A1 (en)	1998-12-24
EP0705831B1 (de)	2003-12-03
US20030149073A1 (en)	2003-08-07
PT705831E (pt)	2004-04-30
JP3901234B2 (ja)	2007-04-04
SG63528A1 (en)	1999-03-30
IL129641A0 (en)	2000-02-29
PH31400A (en)	1998-10-29
IL129641A (en)	2000-08-31
FI108791B (fi)	2002-03-28
SI0705831T1 (en)	2004-02-29
CN1224715A (zh)	1999-08-04
FI954681A0 (fi)	1995-10-02
MY117282A (en)	2004-06-30
CZ256795A3 (en)	1996-04-17
HN1995009160A (es)	2000-04-24
ZA958297B (en)	1996-05-06
TW448175B (en)	2001-08-01
SK284260B6 (sk)	2004-12-01
MA23683A1 (fr)	1996-07-01
US6858622B2 (en)	2005-02-22

Publication	Publication Date	Title
EE9500071A (et)	1996-04-15	Tsükloalkanindool- ja asaindoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud derivaate sisaldavad ravimid ning karboksüülhapped kui vaheühendid nimetatud tsükloalkaanindool- ja asaindoolderivaatide valmistamiseks
HUT74939A (en)	1997-03-28	Imidazopyridine derivatives, process for their production and pharmaceutical compositions containing them
AU2819992A (en)	1993-05-13	Hiv protease inhibitors useful for the treatment of aids
FR2619111B1 (fr)	1991-01-11	Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
ATE73123T1 (de)	1992-03-15	Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
IL119054A (en)	2000-10-31	Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
CO4700467A1 (es)	1998-12-29	Derivados de cephalosporin fluoroquinolonatos y composicio- nes farmaceuticas que los contengan

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2010-06-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20091003